radiolabeled PSMA ligand PET tracers (BC Cancer Agency)

N/A

Report date: 2026/01/28 14:54:06

NME

Base Information

Drug Nameradiolabeled PSMA ligand PET tracers (BC Cancer Agency)

Drug Alias Name177Lu-HTK-03041Fluorine-18-HTK-01070Fluorine18-HTK-01069Fluorine-18-HTK-01146Fluorine-18-HTK-01157 +[16]

ClassificationRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo)Radiation-emitting products > Nuclides > Fluorine > 18F +[6]

Mechanisms of ActionPositron-emission tomography enhancersProstate-Specific Membrane Antigen modulators

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBC Cancer Agency

China Registration ClassN/A

Develop Information

Active CompaniesBC Cancer Agency

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A